Explore Stanford technologies available for licensing:

Stanford researchers have developed a method for identifying the foveal center in the eye for high resolution retinal mapping in adaptive optics devices using artificial intelligence.

For the first time, researchers in Prof. Yan Xia's laboratory have synthesized a new ladder type microporous polymide (PIM) by linking an arene-norbornene building block to a Tröger's base which can be used for high-performance gas separation membranes.

Researchers at Stanford have developed a potent, insulin-based, insulin receptor antagonist that could be used as a hyperinsulinism therapeutic.

Stanford researchers have developed a single-cell technology for a targeted high-throughput multiomic readout of RNA and gDNA.

This invention is an innovative breakthrough in cancer radiotherapy, offering a cutting-edge solution to address the challenges of radio-resistant and immunosuppressive tumors.

Researchers at Stanford have developed a porous biologics-loaded multimaterial construct, called Hybrid Tissue Engineering Construct (HyTEC), with applications in regenerative medicine and therapeutic delivery.

Based on their proprietary HyTEC tissue engineering platform, researchers at Stanford have developed an osteoinductive intramedullary implant (IM) device for improved bone healing.

Researchers at Stanford have developed a biodegradable device and platform carrier of biologics for promoting faster bone healing of large bone defects, fractures, and non-union.

Stanford researchers have developed chemically modified AAV vectors through an unnatural amino acid substitution on the capsid surface for post-production vector engineering through biorthogonal copper-free click chemistry.

Technology Reference
CZ Biohub SF ref. no. CZB-229S
Stanford ref. no. S21-348

Researchers at Stanford have developed a wearable patch that allows for continuous mental health monitoring via electroencephalogram (EEG) recording.

Technology Reference
CZ Biohub SF ref. no. CZB-230S
Stanford ref. no. S21-394

Technology Reference
CZ Biohub SF ref. no. CZB-231S
Stanford ref. no. S21-400

Researchers at Stanford have developed a new microparticle vaccine scaffold for the development of immunogenic subunit vaccines.

Stanford researchers in the Benson Lab have developed CCSNet, an open source software platform for modeling CO₂ storage reservoirs based on machine learning neural networks.

Background

Stanford inventors have developed an early-stage screening method to diagnose abdominal aortic aneurysms (AAA). AAA is a common cardiovascular disease with high prevalence in European men 65 years and above.